vs
GRANITE CONSTRUCTION INC（GVA）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
GRANITE CONSTRUCTION INC的季度营收约是Royalty Pharma plc的1.9倍（$1.2B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 4.5%，领先30.0%），GRANITE CONSTRUCTION INC同比增速更快（19.2% vs 4.8%），过去两年GRANITE CONSTRUCTION INC的营收复合增速更高（31.7% vs 4.6%）
Granite Construction Inc.是美国民用建筑企业及建筑骨料生产商，为标普600指数成分股，创始地及总部位于加利福尼亚州沃森维尔，是Granite Construction Company的母公司。公司主营重型民用建筑承包与建筑骨料生产，在美国西部多州持有或租赁采石场，主要开采砂、砾石、碎石等产品。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
GVA vs RPRX — 直观对比
营收规模更大
GVA
是对方的1.9倍
$622.0M
营收增速更快
GVA
高出14.5%
4.8%
净利率更高
RPRX
高出30.0%
4.5%
两年增速更快
GVA
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $622.0M |
| 净利润 | $52.0M | $214.2M |
| 毛利率 | 14.4% | — |
| 营业利润率 | 6.4% | 62.4% |
| 净利率 | 4.5% | 34.4% |
| 营收同比 | 19.2% | 4.8% |
| 净利润同比 | 25.4% | 2.9% |
| 每股收益（稀释后） | $1.23 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GVARPRX
| Q4 25 | $1.2B | $622.0M | ||
| Q3 25 | $1.4B | $609.3M | ||
| Q2 25 | $1.1B | $578.7M | ||
| Q1 25 | $699.5M | $568.2M | ||
| Q4 24 | $977.3M | $593.6M | ||
| Q3 24 | $1.3B | $564.7M | ||
| Q2 24 | $1.1B | $537.3M | ||
| Q1 24 | $672.3M | $568.0M |
净利润GVARPRX
| Q4 25 | $52.0M | $214.2M | ||
| Q3 25 | $102.9M | $288.2M | ||
| Q2 25 | $71.7M | $30.2M | ||
| Q1 25 | $-33.7M | $238.3M | ||
| Q4 24 | $41.5M | $208.2M | ||
| Q3 24 | $79.0M | $544.0M | ||
| Q2 24 | $36.9M | $102.0M | ||
| Q1 24 | $-31.0M | $4.8M |
毛利率GVARPRX
| Q4 25 | 14.4% | — | ||
| Q3 25 | 18.2% | — | ||
| Q2 25 | 17.7% | — | ||
| Q1 25 | 12.0% | — | ||
| Q4 24 | 15.4% | — | ||
| Q3 24 | 15.9% | — | ||
| Q2 24 | 15.2% | — | ||
| Q1 24 | 8.1% | — |
营业利润率GVARPRX
| Q4 25 | 6.4% | 62.4% | ||
| Q3 25 | 10.0% | 70.1% | ||
| Q2 25 | 9.2% | 36.3% | ||
| Q1 25 | -5.7% | 94.0% | ||
| Q4 24 | 6.2% | 60.9% | ||
| Q3 24 | 8.2% | — | ||
| Q2 24 | 7.9% | 50.2% | ||
| Q1 24 | -6.4% | -13.0% |
净利率GVARPRX
| Q4 25 | 4.5% | 34.4% | ||
| Q3 25 | 7.2% | 47.3% | ||
| Q2 25 | 6.4% | 5.2% | ||
| Q1 25 | -4.8% | 41.9% | ||
| Q4 24 | 4.2% | 35.1% | ||
| Q3 24 | 6.2% | 96.3% | ||
| Q2 24 | 3.4% | 19.0% | ||
| Q1 24 | -4.6% | 0.8% |
每股收益（稀释后）GVARPRX
| Q4 25 | $1.23 | $0.49 | ||
| Q3 25 | $1.98 | $0.67 | ||
| Q2 25 | $1.42 | $0.07 | ||
| Q1 25 | $-0.77 | $0.55 | ||
| Q4 24 | $0.99 | $0.46 | ||
| Q3 24 | $1.57 | $1.21 | ||
| Q2 24 | $0.76 | $0.23 | ||
| Q1 24 | $-0.70 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $600.2M | $618.7M |
| 总债务越低越好 | $1.3B | $9.0B |
| 股东权益账面价值 | $1.2B | $9.7B |
| 总资产 | $4.0B | $19.6B |
| 负债/权益比越低杠杆越低 | 1.14× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资GVARPRX
| Q4 25 | $600.2M | $618.7M | ||
| Q3 25 | $547.2M | $938.9M | ||
| Q2 25 | $385.3M | $631.9M | ||
| Q1 25 | $422.8M | $1.1B | ||
| Q4 24 | $585.6M | $929.0M | ||
| Q3 24 | $472.4M | $950.1M | ||
| Q2 24 | $377.2M | $1.8B | ||
| Q1 24 | $337.3M | $843.0M |
总债务GVARPRX
| Q4 25 | $1.3B | $9.0B | ||
| Q3 25 | $1.3B | $8.9B | ||
| Q2 25 | $740.4M | $8.0B | ||
| Q1 25 | $739.7M | $7.6B | ||
| Q4 24 | $739.0M | $7.6B | ||
| Q3 24 | $738.6M | $7.6B | ||
| Q2 24 | $738.9M | $7.6B | ||
| Q1 24 | $553.2M | $6.1B |
股东权益GVARPRX
| Q4 25 | $1.2B | $9.7B | ||
| Q3 25 | $1.2B | $9.6B | ||
| Q2 25 | $1.1B | $9.5B | ||
| Q1 25 | $993.5M | $9.8B | ||
| Q4 24 | $1.0B | $10.3B | ||
| Q3 24 | $1.0B | $10.3B | ||
| Q2 24 | $931.7M | $9.8B | ||
| Q1 24 | $946.5M | $9.9B |
总资产GVARPRX
| Q4 25 | $4.0B | $19.6B | ||
| Q3 25 | $4.1B | $19.3B | ||
| Q2 25 | $3.1B | $18.3B | ||
| Q1 25 | $2.9B | $17.6B | ||
| Q4 24 | $3.0B | $18.2B | ||
| Q3 24 | $3.1B | $18.0B | ||
| Q2 24 | $2.9B | $17.7B | ||
| Q1 24 | $2.6B | $16.1B |
负债/权益比GVARPRX
| Q4 25 | 1.14× | 0.92× | ||
| Q3 25 | 1.16× | 0.93× | ||
| Q2 25 | 0.70× | 0.84× | ||
| Q1 25 | 0.74× | 0.78× | ||
| Q4 24 | 0.73× | 0.74× | ||
| Q3 24 | 0.73× | 0.74× | ||
| Q2 24 | 0.79× | 0.78× | ||
| Q1 24 | 0.58× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $179.3M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $128.8M | — |
| 自由现金流率自由现金流/营收 | 11.0% | — |
| 资本支出强度资本支出/营收 | 4.3% | — |
| 现金转化率经营现金流/净利润 | 3.45× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $330.6M | — |
8季度趋势，按日历期对齐
经营现金流GVARPRX
| Q4 25 | $179.3M | $827.1M | ||
| Q3 25 | $284.2M | $702.6M | ||
| Q2 25 | $1.8M | $364.0M | ||
| Q1 25 | $3.6M | $596.1M | ||
| Q4 24 | $172.8M | $742.5M | ||
| Q3 24 | $261.5M | $703.6M | ||
| Q2 24 | $-2.0M | $658.2M | ||
| Q1 24 | $24.1M | $664.6M |
自由现金流GVARPRX
| Q4 25 | $128.8M | — | ||
| Q3 25 | $257.5M | — | ||
| Q2 25 | $-27.0M | — | ||
| Q1 25 | $-28.6M | — | ||
| Q4 24 | $144.6M | — | ||
| Q3 24 | $220.2M | — | ||
| Q2 24 | $-41.0M | — | ||
| Q1 24 | $-3.8M | — |
自由现金流率GVARPRX
| Q4 25 | 11.0% | — | ||
| Q3 25 | 18.0% | — | ||
| Q2 25 | -2.4% | — | ||
| Q1 25 | -4.1% | — | ||
| Q4 24 | 14.8% | — | ||
| Q3 24 | 17.3% | — | ||
| Q2 24 | -3.8% | — | ||
| Q1 24 | -0.6% | — |
资本支出强度GVARPRX
| Q4 25 | 4.3% | — | ||
| Q3 25 | 1.9% | — | ||
| Q2 25 | 2.6% | — | ||
| Q1 25 | 4.6% | — | ||
| Q4 24 | 2.9% | — | ||
| Q3 24 | 3.2% | — | ||
| Q2 24 | 3.6% | — | ||
| Q1 24 | 4.1% | — |
现金转化率GVARPRX
| Q4 25 | 3.45× | 3.86× | ||
| Q3 25 | 2.76× | 2.44× | ||
| Q2 25 | 0.02× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | 4.17× | 3.57× | ||
| Q3 24 | 3.31× | 1.29× | ||
| Q2 24 | -0.05× | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GVA
| Public | $680.2M | 58% |
| Private | $260.1M | 22% |
| Asphalt | $116.9M | 10% |
| Aggregates | $107.9M | 9% |
| Collaborative Arrangement | $7.0M | 1% |
| Performance Obligations | $3.5M | 0% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
